Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fistula × Certolizumab Pegol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 5 Arthritis, Rheumatoid 4 Lymphoma, Follicular 1 Lung Neoplasms 1 Fistula 1 Adenocarcinoma of Lung 1

Interventions

Surgical Procedures, Operative 2 Stents 2 Tomography, X-Ray Computed 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Protons 1 Octreotide 1 Hydrocortisone 1 Endoscopy 1 Conservative Treatment 1 Cholangiopancreatography, Endoscopic Retrograde 1 Certolizumab Pegol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00354367 2012-05-28

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

UCB Pharma

Phase 3 Withdrawn

Crohn Disease, Fistula

Data powered by HemOnc (CC BY 4.0) Colophon ⚡